Product NDC: | 54738-951 |
Proprietary Name: | ribavirin |
Non Proprietary Name: | ribavirin |
Active Ingredient(s): | 400 mg/1 & nbsp; ribavirin |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54738-951 |
Labeler Name: | Richmond Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077456 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080601 |
Package NDC: | 54738-951-56 |
Package Description: | 56 TABLET, FILM COATED in 1 BOTTLE (54738-951-56) |
NDC Code | 54738-951-56 |
Proprietary Name | ribavirin |
Package Description | 56 TABLET, FILM COATED in 1 BOTTLE (54738-951-56) |
Product NDC | 54738-951 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ribavirin |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20080601 |
Marketing Category Name | ANDA |
Labeler Name | Richmond Pharmaceuticals, Inc. |
Substance Name | RIBAVIRIN |
Strength Number | 400 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |